- Previous Close
0.9900 - Open
1.0000 - Bid 0.9800 x 351000
- Ask 0.9900 x 350000
- Day's Range
0.9900 - 1.0000 - 52 Week Range
0.9500 - 2.6600 - Volume
5,513 - Avg. Volume
29,781 - Market Cap (intraday)
69.776M - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1000 - Earnings Date Feb 19, 2025 - Feb 25, 2025
- Forward Dividend & Yield 0.04 (4.04%)
- Ex-Dividend Date Apr 3, 2024
- 1y Target Est
1.22
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also provides solutions for digestive health, skin health, heart and metabolic health, and immunity. In addition, the company engages in the apiary ownership and forest management. It offers its products through supermarkets, department stores, and health stores, as well as online. Comvita Limited was incorporated in 1974 and is based in Te Puke, New Zealand.
www.comvita.co.nzRecent News: CVT.NZ
View MorePerformance Overview: CVT.NZ
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CVT.NZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CVT.NZ
View MoreValuation Measures
Market Cap
139.55M
Enterprise Value
240.82M
Trailing P/E
22.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.34
Price/Book (mrq)
0.43
Enterprise Value/Revenue
1.18
Enterprise Value/EBITDA
10.93
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.87%
Return on Assets (ttm)
-2.12%
Return on Equity (ttm)
-38.70%
Revenue (ttm)
204.34M
Net Income Avi to Common (ttm)
-77.39M
Diluted EPS (ttm)
-1.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
8.16M
Total Debt/Equity (mrq)
68.12%
Levered Free Cash Flow (ttm)
-80.38k